India's pharmaceutical industry is set for growth, driven by strong market players, global reputation, and evolving trends.

Indian pharmaceutical companies lag behind global peers in ESG practices, facing regulatory, awareness, and resource ...

BatchMaster Software is proud to welcome Erawat Pharma, one of central India's most prestigious pharmaceutical manufacturers, ...

Mumbai: Bajaj Healthcare Limited has announced that it has received approval from the Drug Controller General of India (DCGI) ...

This article is authored by Saransh Chaudhary, president, Global Critical Care, Venus Remedies Ltd and CEO, Venus Medicine ...

Vedanta, Nuvama, Punjab National Bank, IndusInd Bank, and Bandhan Bank will be among 135 companies to release their reports ...

The government may extend the deadline for drug manufacturers to comply with revised Schedule M standards until December 2025 ...

NEW DELHI: India is bracing for possible disruptions to its pharmaceutical industry - where the American market accounts for ...

Expert Chahat Aggarwal anticipates a growing pharmaceutical industry backed by government initiatives in the Union Budget ...

The Nifty Pharma index fell nearly 3% in intraday trade on January 28, marking its third consecutive session of decline, with ...

The Indian pharmaceutical and healthcare industry seeks increased government support in Budget 2025 to enhance in ...